Will Gilead, the acquirer, be Gilead, the acquired? Not likely

In 2012, Gilead CEO Dan O'Day replaced AstraZeneca CEO (and onetime Genentech CEO) Pascal Soriot as chief operating officer of Roche Pharma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.